PLASMABLASTIC LYMPHOMA
Clinical trials for PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for HIV patients with aggressive lymphoma
Disease control Recruiting nowThis early-phase trial is testing whether adding the drug pomalidomide to standard chemotherapy (with or without rituximab) is safe and effective for people with HIV who have certain aggressive lymphomas. About 25 adults with high-risk features will receive up to 6 cycles of trea…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
New drug SGR-1505 enters early human testing for blood cancers
Disease control Recruiting nowThis early-phase study tests a new drug called SGR-1505 in about 98 adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to check safety and find the best dose. Participants will receive the drug and be monitored for side effects and how the d…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Promising combo targets hard-to-treat blood cancer in early trial
Disease control Recruiting nowThis study tests whether adding daratumumab to two standard drugs (bortezomib and dexamethasone) can shrink tumors in people with a rare, aggressive blood cancer called plasmablastic lymphoma that has returned or not responded to prior therapy. About 28 adults will receive the co…
Matched conditions: PLASMABLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Scientists dig into past cases of rare lymphoma to uncover clues for future care
Knowledge-focused Recruiting nowThis study will review medical records from 200 people diagnosed with plasmablastic lymphoma, a rare and aggressive blood cancer. Researchers aim to learn more about the disease's features, treatments used, and what affects patient survival. No new treatments are given; the goal …
Matched conditions: PLASMABLASTIC LYMPHOMA
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated May 26, 2026 10:28 UTC